LL37 induces VEGF expression in dental pulp cells through ERK signalling

International Endodontic Journal

Volumn 48, Issue 7, 2015, Pages 673-679

  Khung, R ^a   Shiba, H ^a   Kajiya, M ^a   Kittaka, M ^a   Ouhara, K ^a   Takeda, K ^a   Mizuno, N ^a   Fujita, T ^a   Komatsuzawa, H ^b   Kurihara, H ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ERK; LL37; Pulp cells; Vascular endothelial growth factor

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VITRO STUDY; MAPK SIGNALING; PHOSPHORYLATION; PREMOLAR TOOTH; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOOTH PULP; UPREGULATION; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BICUSPID; BLOTTING, WESTERN; CATHELICIDINS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELLS, CULTURED; DENTAL PULP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IN VITRO TECHNIQUES; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930373650     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/iej.12365     Document Type: Article

References (34)

1. Agerberth B, Charo J, Werr J et al. (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-93.
2. Artese L, Rubini C, Ferrero G, Fioroni M, Santinelli A, Piattelli A (2002) Vascular endothelial growth factor (VEGF) expression in healthy and inflamed human dental pulps. Journal of Endodontics 28, 20-3.
3. Bals R, Wang X, Zasloff M, Wilson JM (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America 95, 9541-6.
4. Brown LF, Berse B, Tognazzi K et al. (1992) Vascular permeability factor mRNA and protein expression in human kidney. Kidney International 42, 1457-61.
5. Bucki R, Leszczyńska K, Namiot A, Sokolowski W (2010) Cathelicidin LL-37: a multitask antimicrobial peptide. Archivum Immunologiae et Therapiae Experimentalis 58, 15-25.
6. Connolly DT, Heuvelman DM, Nelson R et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. Journal of Clinical Investigation 84, 1470-8.
7. Dvorak HF (2005) Angiogenesis: update 2005. Journal of Thrombosis and Haemostasis 3, 1835-42.
8. Elssner A, Duncan M, Gavrilin M, Wewers MD (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. Journal of Immunology 172, 4987-94.
9. Favard C, Moukadiri H, Dorey C, Praloran V, Plouët J (1991) Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biology of the Cell 73, 1-6.
10. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25, 581-611.
11. Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N, Ståhle-Bäckdahl M (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infection and Immunity 67, 2561-6.
12. Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M (2012) Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene 31, 352-65.
13. Kajiya M, Shiba H, Fujita T et al. (2008) Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts. Journal of Biological Chemistry 283, 16259-67.
14. Kajiya M, Shiba H, Komatsuzawa H et al. (2010) The antimicrobial peptide LL37 induces the migration of human pulp cells: a possible adjunct for regenerative endodontics. Journal of Endodontics 36, 1009-13.
15. Kittaka M, Shiba H, Kajiya M et al. (2013) Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells. Journal of Periodontal Research 48, 228-34.
16. Koczulla R, von Degenfeld G, Kupatt C et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. Journal of Clinical Investigation 111, 1665-72.
17. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infection and Immunity 63, 1291-7.
18. Matsushita K, Motani R, Sakuta T et al. (2000) The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. Journal of Dental Research 79, 1596-603.
19. Midorikawa K, Ouhara K, Komatsuzawa H et al. (2003) Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infection and Immunology 71, 3730-9.
20. Nakashima M, Akamine A (2005) The application of tissue engineering to regeneration of pulp and dentin in endodontics. Journal of Endodontics 31, 711-8.
21. Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Current Opinion in Hematology 16, 41-7.
22. O'Connor DS, Schechner JS, Adida C et al. (2000) Control of apoptosis during angiogenesis by survivin expression in endothelial cells. American Journal of Pathology 156, 393-8.
23. Ouhara K, Komatsuzawa H, Yamada S et al. (2005) Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. Journal of Antimicrobial Chemotherapy 55, 888-96.
24. Pertovaara L, Kaipainen A, Mustonen T et al. (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. Journal of Biological Chemistry 269, 6271-4.
25. Pintucci G, Froum S, Pinnell J, Mignatti P, Rafii S, Green D (2002) Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thrombosis and Haemostasis 88, 834-42.
26. Roskoski R Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 62, 179-213.
27. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-5.
28. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD, Smith SK (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. Journal of Reproduction and Fertility 99, 609-15.
29. Shiba H, Mouri Y, Komatsuzawa H et al. (2003) Macrophage inflammatory protein-3alpha and beta-defensin-2 stimulate dentin sialophosphoprotein gene expression in human pulp cells. Biochemical and Biophysical Research Communications 306, 867-71.
30. Tjäderhane L (2002) The mechanism of pulpal wound healing. Australian Endodontic Journal 28, 68-74.
31. Tran-Hung L, Mathieu S, About I (2006) Role of human pulp fibroblasts in angiogenesis. Journal of Dental Research 85, 819-23.
32. Tran-Hung L, Laurent P, Camps J, About I (2008) Quantification of angiogenic growth factors released by human dental cells after injury. Archives of Oral Biology 53, 9-13.
33. Vlodavsky I, Fuks Z, Ishai-Michaeli R et al. (1991) Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. Journal of Cellular Biochemistry 45, 167-76.
34. Zanetti M, Gennaro R, Romeo D (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Letters 374, 1-5.